Deutsche Bank Ag\ Catalyst Pharmaceuticals, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 578,208 shares of CPRX stock, worth $12.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

578,208

Previous 625,208 7.52%

Holding current value

$12.4 Million

Previous $9.68 Million 18.69%

% of portfolio

0.0%

Previous 0.0%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$15.19 - $21.35 $713,930 - $1 Million	-47,000 Reduced 7.52%	578,208 $11.5 Million
Q2 2024 Aug 14, 2024	SELL	$14.68 - $16.92 $15,340 - $17,681	-1,045 Reduced 0.17%	625,208 $9.68 Million
Q1 2024 May 15, 2024	BUY	$13.18 - $17.11 $94,461 - $122,627	7,167 Added 1.16%	626,253 $9.98 Million
Q4 2023 Feb 14, 2024	BUY	$11.78 - $17.29 $6.04 Million - $8.87 Million	512,829 Added 482.63%	619,086 $10.4 Million
Q3 2023 Nov 09, 2023	SELL	$11.69 - $15.02 $9.99 Million - $12.8 Million	-854,991 Reduced 88.95%	106,257 $1.24 Million
Q2 2023 Aug 14, 2023	BUY	$11.5 - $18.08 $304,865 - $479,300	26,510 Added 2.84%	961,248 $12.9 Million
Q1 2023 May 15, 2023	SELL	$14.34 - $21.05 $2.1 Million - $3.09 Million	-146,710 Reduced 13.57%	934,738 $15.5 Million
Q4 2022 Feb 13, 2023	SELL	$12.25 - $19.5 $761,986 - $1.21 Million	-62,203 Reduced 5.44%	1,081,448 $20.1 Million
Q3 2022 Nov 14, 2022	BUY	$7.06 - $15.52 $7.72 Million - $17 Million	1,094,054 Added 2205.89%	1,143,651 $14.7 Million
Q2 2022 Aug 11, 2022	SELL	$6.23 - $8.57 $22,963 - $31,589	-3,686 Reduced 6.92%	49,597 $348,000
Q1 2022 May 13, 2022	SELL	$5.31 - $8.31 $31,010 - $48,530	-5,840 Reduced 9.88%	53,283 $442,000
Q4 2021 Feb 11, 2022	BUY	$5.21 - $7.45 $16,156 - $23,102	3,101 Added 5.54%	59,123 $400,000
Q3 2021 Nov 04, 2021	SELL	$4.85 - $6.04 $8,696 - $10,829	-1,793 Reduced 3.1%	56,022 $297,000
Q2 2021 Aug 11, 2021	SELL	$4.29 - $6.05 $42,217 - $59,538	-9,841 Reduced 14.55%	57,815 $332,000
Q1 2021 May 13, 2021	SELL	$3.45 - $4.69 $20,375 - $27,699	-5,906 Reduced 8.03%	67,656 $311,000
Q4 2020 Feb 16, 2021	BUY	$2.97 - $3.83 $46,664 - $60,176	15,712 Added 27.16%	73,562 $245,000
Q3 2020 Nov 12, 2020	BUY	$2.97 - $5.08 $17,220 - $29,453	5,798 Added 11.14%	57,850 $172,000
Q2 2020 Aug 13, 2020	SELL	$3.48 - $5.05 $1.51 Million - $2.2 Million	-435,255 Reduced 89.32%	52,052 $240,000
Q1 2020 May 14, 2020	SELL	$2.61 - $5.21 $5,929 - $11,837	-2,272 Reduced 0.46%	487,307 $1.88 Million
Q4 2019 Feb 14, 2020	BUY	$3.67 - $5.7 $1.69 Million - $2.63 Million	461,609 Added 1650.37%	489,579 $1.84 Million
Q3 2019 Nov 14, 2019	SELL	$3.89 - $7.43 $226,172 - $431,995	-58,142 Reduced 67.52%	27,970 $146,000
Q2 2019 Aug 14, 2019	SELL	$2.7 - $6.11 $102,999 - $233,084	-38,148 Reduced 30.7%	86,112 $330,000
Q1 2019 May 15, 2019	SELL	$2.11 - $5.33 $3,806 - $9,615	-1,804 Reduced 1.43%	124,260 $631,000
Q4 2018 Feb 14, 2019	SELL	$1.92 - $3.62 $387,014 - $729,683	-201,570 Reduced 61.52%	126,064 $241,000
Q3 2018 Dec 21, 2021	BUY	$2.81 - $3.78 $71,402 - $96,049	25,410 Added 8.41%	327,634 $1.24 Million
Q3 2018 Nov 14, 2018	BUY	$2.81 - $3.78 $301,262 - $405,257	107,211 Added 54.98%	302,224 $1.14 Million
Q2 2018 Apr 21, 2020	BUY	$2.26 - $3.84 $70,760 - $120,230	31,310 Added 19.13%	195,013 $608,000
Q2 2018 Aug 14, 2018	SELL	$2.26 - $3.84 $1.36 Million - $2.31 Million	-600,273 Reduced 78.57%	163,703 $510,000
Q1 2018 Oct 18, 2019	BUY	$2.39 - $4.01 $49,241 - $82,618	20,603 Added 2.77%	763,976 $1.83 Million
Q1 2018 May 15, 2018	BUY	$2.39 - $4.01 $193,281 - $324,292	80,871 Added 12.21%	743,373 $1.78 Million
Q4 2017 Feb 14, 2018	BUY	$2.51 - $4.4 $542,398 - $950,818	216,095 Added 48.41%	662,502 $2.59 Million
Q3 2017 Nov 14, 2017	BUY	$2.4 - $2.94 $1.07 Million - $1.31 Million	446,407	446,407 $1.12 Million

Others Institutions Holding CPRX

# of Institutions

326

Shares Held

94M

Call Options Held

19.1K

Put Options Held

51.1K

View Full List

About CATALYST PHARMACEUTICALS, INC.

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.21B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

More about CPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account